Mayer Arie 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Mayer Arie
Director
Transactions
- Award
Common Stock
2025-12-31+30,000→ 163,109 total - Award
Common Stock
2025-12-31+4,900→ 168,009 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
- [F2]Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.